ARETÉ STRATEGIES BIO-PHARMA ADVISORS Trademark

Trademark Overview

On Tuesday, May 8, 2012, a trademark application was filed for ARETÉ STRATEGIES BIO-PHARMA ADVISORS with the United States Patent and Trademark Office. The USPTO has given the ARETÉ STRATEGIES BIO-PHARMA ADVISORS trademark a serial number of 85619846. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 30, 2021. The ARETÉ STRATEGIES BIO-PHARMA ADVISORS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting services, namely, product and service commercialization services for pharmaceutical, biotechnology, diagnostic technology, medical device, vaccine production, and life sciences technology customers in the field of health care products and services
aretÉ strategies bio-pharma advisors

General Information

Serial Number85619846
Word MarkARETÉ STRATEGIES BIO-PHARMA ADVISORS
Filing DateTuesday, May 8, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 30, 2021
Registration Number4768986
Registration DateTuesday, July 7, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 17, 2013

Trademark Statements

Description of MarkThe mark consists of the word "ARETÉ" appearing in bold and above the word "STRATEGIES" in all capital letters which is above the phrase "BIO-PHARMA ADVISORS". All the wording is centered between six curved bands, three stacked to the left of the wording and three stacked to the right of the wording.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting services, namely, product and service commercialization services for pharmaceutical, biotechnology, diagnostic technology, medical device, vaccine production, and life sciences technology customers in the field of health care products and services
NOT AVAILABLE"STRATEGIES BIO-PHARMA ADVISORS"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 15, 2012
Primary Code035
First Use Anywhere DateWednesday, August 31, 2011
First Use In Commerce DateWednesday, August 31, 2011

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressPalo Alto, CA 94304
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMinneapolis, MN 55402
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMinneapolis, MN 55402

Trademark Events

Event DateEvent Description
Friday, September 28, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 11, 2012NEW APPLICATION ENTERED
Tuesday, May 15, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 16, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, August 28, 2012ASSIGNED TO EXAMINER
Friday, September 7, 2012NON-FINAL ACTION WRITTEN
Friday, September 7, 2012NON-FINAL ACTION E-MAILED
Friday, September 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 27, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 29, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 1, 2012NON-FINAL ACTION WRITTEN
Thursday, November 1, 2012NON-FINAL ACTION E-MAILED
Thursday, November 1, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 1, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 29, 2013ASSIGNED TO EXAMINER
Wednesday, May 29, 2013SUSPENSION LETTER WRITTEN
Wednesday, May 29, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, November 12, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 24, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 8, 2013ASSIGNED TO LIE
Tuesday, August 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 28, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2013PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 9, 2014NOTICE OF REVIVAL - E-MAILED
Thursday, May 1, 2014SOU TEAS EXTENSION RECEIVED
Thursday, May 1, 2014SOU EXTENSION 1 FILED
Wednesday, May 28, 2014SOU EXTENSION 1 GRANTED
Friday, May 23, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 8, 2014SOU EXTENSION 2 FILED
Monday, December 8, 2014TEAS PETITION TO REVIVE RECEIVED
Monday, December 8, 2014PETITION TO REVIVE-GRANTED
Monday, December 8, 2014SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, December 10, 2014SOU EXTENSION 2 GRANTED
Thursday, December 11, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 3, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 18, 2021TEAS SECTION 8 & 15 RECEIVED
Monday, May 11, 2015TEAS STATEMENT OF USE RECEIVED
Monday, May 11, 2015USE AMENDMENT FILED
Thursday, May 28, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 2, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 14, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, July 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

advisors pharma strategies aret services technology sciences life production vaccine customers field products care